Optimizing the treatment of acute lymphoblastic leukemia in younger and older adults: new drugs and evolving paradigms
Nicholas J. Short, Hagop M. Kantarjian, Elias Jabbour
Topics & Concepts
BlinatumomabPonatinibMedicineChimeric antigen receptorOncologyHematopoietic stem cell transplantationCD19Clinical trialImmunologyInternal medicineTransplantationImmunotherapyAntibodyTyrosine kinaseImmune systemDasatinibReceptorAcute Lymphoblastic Leukemia researchCAR-T cell therapy researchChildhood Cancer Survivors' Quality of Life